文献速递儿童心血管与肾脏

儿童青少年高血压与长期心血管结局的关联

Long-Term Cardiovascular Outcomes in Children and Adolescents With Hypertension.
PubMed 文献 · JAMA Pediatr · 2024-01-01

中位随访13.6年发现,高血压患儿主要不良心血管事件(MACE)发生率为4.6/1000人年,对照组为2.2/1000人年,风险比2.1(95%CI 1.9-2.2)。

要点

  • 儿童高血压与长期MACE风险升高相关,风险比为2.1(95%CI 1.9-2.2)。
  • 高血压患儿卒中、心肌梗死或不稳定心绞痛住院、冠脉介入及心衰风险更高。
  • 高血压患儿心血管死亡风险未显著升高。

核心结论

  • 诊断为高血压的儿童与无高血压对照相比,长期MACE关联风险更高。
  • 改善儿童高血压的检出、随访和控制可能降低成年心血管疾病风险。

研究设计与样本

  • 研究为基于人群的回顾性匹配队列研究,1996至2022年开展。
  • 纳入1996至2021年加拿大安大略省存活的所有3-18岁儿童,排除既往肾脏替代治疗者。
  • 高血压患儿与无高血压对照按年龄、性别、出生体重、母亲妊娠期高血压、既往合并症及倾向评分以1:5匹配。

主要发现

  • 中位随访13.6年(IQR 7.8-19.5)期间,MACE发生率为高血压组4.6/1000人年 vs 对照组2.2/1000人年,HR 2.1(95%CI 1.9-2.2)。
  • 高血压患儿卒中、心肌梗死或不稳定心绞痛住院、冠脉介入及充血性心力衰竭的关联风险更高,但心血管死亡无差异。

关键数值与推荐

  • 高血压暴露通过经验证的病例定义结合诊断和医生账单索赔识别。
  • 主要结局MACE为心血管死亡、卒中、心肌梗死或不稳定心绞痛住院或冠脉介入的复合终点。

临床怎么用

  • 儿科医生应重视儿童高血压的检出与规范随访,以可能降低远期心血管风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Hypertension affects 6% of all children, and its prevalence is increasing. Childhood hypertension tracks into adulthood and is associated with subclinical cardiovascular disease; however, there is a lack of evidence linking childhood hypertension to cardiovascular outcomes, which may contribute to underdiagnosis and undertreatment. OBJECTIVE: To determine the long-term associated risk of major adverse cardiac events (MACE) among children diagnosed with hypertension. DESIGN, SETTING, AND PARTICIPANTS: This was a population-based, retrospective, matched cohort study conducted from 1996 to 2022. The study included all children (aged 3-18 years) alive in Ontario, Canada, from 1996 to 2021, who were identified using provincial administrative health databases. Children with prior kidney replacement therapy were excluded. EXPOSURE: Incident hypertension diagnosis, identified by validated case definitions using diagnostic and physician billing claims. Each case was matched with 5 controls without hypertension by age, sex, birth weight, maternal gestational hypertension, prior comorbidities (chronic kidney disease, diabetes, cardiovascular surgery), and a propensity score for hypertension. MAIN OUTCOMES AND MEASURES: The primary outcome was MACE (a composite of cardiovascular death, stroke, hospitalization for myocardial infarction or unstable angina, or coronary intervention). Time to MACE was evaluated using the Kaplan-Meier method and Cox proportional hazards regression. RESULTS: A total of 25 605 children (median [IQR] age, 15 [11-17] years; 14 743 male [57.6%]) with hypertension were matched to 128 025 controls without hypertension. Baseline covariates were balanced after propensity score matching, and prior comorbidities were uncommon (hypertension vs control cohort: malignancy, 1451 [5.7%] vs 7908 [6.2%]; congenital heart disease, 1089 [4.3%] vs 5408 [4.2%]; diabetes, 482 [1.9%] vs 2410 [1.9%]). During a median (IQR) of 13.6 (7.8-19.5) years of follow-up, incidence of MACE was 4.6 per 1000 person-years in children with hypertension vs 2.2 per 1000 person-years in controls (hazard ratio, 2.1; 95% CI, 1.9-2.2). Children with hypertension were at higher associated risk of stroke, hospitalization for myocardial infarction or unstable angina, coronary intervention, and congestive heart failure, but not cardiovascular death, compared with nonhypertensive controls. CONCLUSIONS AND RELEVANCE: Children diagnosed with hypertension had a higher associated long-term risk of MACE compared with controls without hypertension. Improved detection, follow-up, and control of pediatric hypertension may reduce the risk of adult cardiovascular disease.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Robinson CH, Hussain J, Jeyakumar N, et al. Long-Term Cardiovascular Outcomes in Children and Adolescents With Hypertension. JAMA Pediatr. 2024. PMID: 38709137. doi:10.1001/jamapediatrics.2024.1543

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。